• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease-A Case-Control Study.溶血性疾病新生儿胆汁淤积症的发病率及危险因素——一项病例对照研究
J Clin Med. 2024 May 29;13(11):3190. doi: 10.3390/jcm13113190.
2
Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.1996年至2010年美国胎儿及新生儿溶血病的活产患病率。
AJOG Glob Rep. 2023 Mar 24;3(2):100203. doi: 10.1016/j.xagr.2023.100203. eCollection 2023 May.
3
Management and Treatment Outcomes of Hemolytic Disease of the Fetus and Newborn (HDFN)-A Retrospective Cohort Study.胎儿和新生儿溶血病(HDFN)的管理与治疗结果——一项回顾性队列研究
J Clin Med. 2024 Aug 14;13(16):4785. doi: 10.3390/jcm13164785.
4
Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.新生儿重度 RhC 溶血病与 RhD 溶血病的产后结局比较。
Transfusion. 2013 Jul;53(7):1580-5. doi: 10.1111/j.1537-2995.2012.03937.x. Epub 2012 Nov 1.
5
Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review.胎儿和新生儿溶血病宫内输血后的新生儿结局:二十年服务回顾。
J Matern Fetal Neonatal Med. 2022 Dec;35(25):10220-10225. doi: 10.1080/14767058.2022.2122041. Epub 2022 Sep 18.
6
[Retrospective Analysis of Irregular Antibodies Causing Hemolytic Disease of the Fetus and Newborn in Jiangxi Province].[江西省引起胎儿及新生儿溶血病的不规则抗体回顾性分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Feb;31(1):215-220. doi: 10.19746/j.cnki.issn.1009-2137.2023.01.034.
7
Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes.胎儿和新生儿溶血病:产后护理和结局的快速复习。
BMC Pregnancy Childbirth. 2023 Oct 18;23(1):738. doi: 10.1186/s12884-023-06061-y.
8
Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.胎儿和新生儿溶血病:产前全景的系统文献回顾。
BMC Pregnancy Childbirth. 2023 Jan 7;23(1):12. doi: 10.1186/s12884-022-05329-z.
9
Liver Dysfunction with Severe Cholestasis and Coagulation Disorders in the Course of Hemolytic Disease of the Newborn Requiring Chelation Therapy-A Case Report and Review of the Literature.新生儿溶血病病程中出现肝功能障碍伴严重胆汁淤积及凝血障碍并需螯合治疗——病例报告及文献复习
J Clin Med. 2023 Dec 13;12(24):7645. doi: 10.3390/jcm12247645.
10
Severe Cholestasis in Neonates with Hemolytic Disease of the Fetus and Newborn-A Case Report.胎儿和新生儿溶血病新生儿的严重胆汁淤积——病例报告
J Clin Med. 2024 Feb 23;13(5):1272. doi: 10.3390/jcm13051272.

引用本文的文献

1
Advancing Clinical Outcomes in Maternal-Fetal Medicine.推进母胎医学的临床治疗效果
J Clin Med. 2025 Jun 10;14(12):4104. doi: 10.3390/jcm14124104.
2
Reply to Teng et al. Comment on "Drozdowska-Szymczak et al. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease-A Case-Control Study. 2024, , 3190".对滕等人的回复。关于“德罗兹多夫斯卡-希姆恰克等人。溶血性疾病新生儿胆汁淤积症的发病率及危险因素——一项病例对照研究。2024年,,3190”的评论
J Clin Med. 2024 Nov 22;13(23):7048. doi: 10.3390/jcm13237048.
3
Comment on Drozdowska-Szymczak et al. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease-A Case-Control Study. 2024, , 3190.对德罗兹多夫斯卡-希姆恰克等人的评论。溶血性疾病新生儿胆汁淤积的发病率和危险因素——一项病例对照研究。2024年,,3190。
J Clin Med. 2024 Nov 22;13(23):7047. doi: 10.3390/jcm13237047.

本文引用的文献

1
Severe Cholestasis in Neonates with Hemolytic Disease of the Fetus and Newborn-A Case Report.胎儿和新生儿溶血病新生儿的严重胆汁淤积——病例报告
J Clin Med. 2024 Feb 23;13(5):1272. doi: 10.3390/jcm13051272.
2
Liver Dysfunction with Severe Cholestasis and Coagulation Disorders in the Course of Hemolytic Disease of the Newborn Requiring Chelation Therapy-A Case Report and Review of the Literature.新生儿溶血病病程中出现肝功能障碍伴严重胆汁淤积及凝血障碍并需螯合治疗——病例报告及文献复习
J Clin Med. 2023 Dec 13;12(24):7645. doi: 10.3390/jcm12247645.
3
Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.临床实践指南修订:孕35周及以上新生儿高胆红素血症的管理
Pediatrics. 2022 Sep 1;150(3). doi: 10.1542/peds.2022-058859.
4
Population-based incidence and risk factors for cholestasis in hemolytic disease of the fetus and newborn.基于人群的胎儿和新生儿溶血病胆汁淤积的发生率及危险因素。
J Perinatol. 2022 Jun;42(6):702-707. doi: 10.1038/s41372-022-01345-1. Epub 2022 Feb 22.
5
Management of severe hyperbilirubinemia in the cholestatic neonate: a review and an approach.胆汁淤积性新生儿重度高胆红素血症的管理:综述与处理方法
J Perinatol. 2022 Jun;42(6):695-701. doi: 10.1038/s41372-022-01330-8. Epub 2022 Feb 10.
6
Hemolytic Disease of the Newborn: A Review of Current Trends and Prospects.新生儿溶血病:当前趋势与前景综述
Pediatric Health Med Ther. 2021 Oct 7;12:491-498. doi: 10.2147/PHMT.S327032. eCollection 2021.
7
Severe Fetal Hemolysis and Cholestasis Due to High-Titer Maternal IgG Anti-A Antibodies.严重胎儿溶血性疾病和胆汁淤积症与高滴度 IgG 抗-A 抗体有关。
Pediatrics. 2019 Apr;143(4). doi: 10.1542/peds.2018-2859. Epub 2019 Mar 14.
8
Chelation therapy for secondary neonatal iron over load: Lessons learned from rhesus hemolytic disease.继发性新生儿铁过载的螯合疗法:从恒河猴溶血病中吸取的教训
Turk J Pediatr. 2018;60(3):335-339. doi: 10.24953/turkjped.2018.03.018.
9
Immunoglobulin for alloimmune hemolytic disease in neonates.新生儿同种免疫性溶血病用免疫球蛋白
Cochrane Database Syst Rev. 2018 Mar 18;3(3):CD003313. doi: 10.1002/14651858.CD003313.pub2.
10
Hepatic Imaging in Neonates and Young Infants: State of the Art.新生儿和婴儿肝脏成像:现状。
Radiology. 2017 Dec;285(3):763-777. doi: 10.1148/radiol.2017170305.

溶血性疾病新生儿胆汁淤积症的发病率及危险因素——一项病例对照研究

Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease-A Case-Control Study.

作者信息

Drozdowska-Szymczak Agnieszka, Mazanowska Natalia, Pomianek Tomasz, Ludwin Artur, Krajewski Paweł

机构信息

Department of Neonatology and Neonatal Intensive Care, Institute of Mother and Child, Kasprzaka 17a, 01-211 Warsaw, Poland.

Department of Obstetrics and Gynecology, Institute of Mother and Child, Kasprzaka 17a, 01-211 Warsaw, Poland.

出版信息

J Clin Med. 2024 May 29;13(11):3190. doi: 10.3390/jcm13113190.

DOI:10.3390/jcm13113190
PMID:38892901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11172419/
Abstract

: One of the rare causes of cholestasis may be hemolytic disease of the fetus and newborn (HDFN). : We retrospectively analyzed 88 medical records of HDFN newborns with cholestasis and 186 records of children with HDFN without cholestasis and conducted an observational, case-control, retrospective study. : Factors influencing the risk of cholestasis were lower gestational age at birth (36.83 ± 1.9 vs. 37.57 ± 1.8, = 0.002), Rh or Kidd HDFN (80.7% vs. 53.2%), and the need for intrauterine transfusion (27.3 vs. 11.8%). The subjects had lower hemoglobin concentrations at birth (14.01 ± 3.8 vs. 16.39 ± 2.8 g/dL) and during whole hospital stay, higher cord blood total bilirubin concentration (4.26 ± 1.8 vs. 2.39 ± 1.4 mg/dL), higher maximum bilirubin concentration (15.27 ± 5.8 vs. 10.24 ± 3.4 mg/dL), and more frequent liver ultrasound abnormalities (19.9 vs. 6.3%). They also required more extended hospitalization due to higher rates of postnatal blood transfusion (33 vs. 3.8%), more frequent need for exchange transfusion (8.8% vs. 2.2%), more extended time and higher risk of phototherapy (94.3 vs. 59.1%), and higher usage of immunoglobulins (55.7 vs. 8.1%), parenteral nutrition (45.5 vs. 12.9%), and antibiotics (14.8 vs. 4.8%). : The risk factors for cholestasis in children with HDFN are lower gestational age at delivery, Rh and Kidd serological type of HDFN, and the need for intrauterine transfusions.

摘要

胎儿和新生儿溶血病(HDFN)可能是胆汁淤积症的罕见病因之一。我们回顾性分析了88例患有胆汁淤积症的HDFN新生儿的病历以及186例无胆汁淤积症的HDFN儿童的病历,并进行了一项观察性、病例对照、回顾性研究。影响胆汁淤积风险的因素包括出生时孕周较小(36.83±1.9 vs. 37.57±1.8,P = 0.002)、Rh或基德HDFN(80.7% vs. 53.2%)以及宫内输血需求(27.3 vs. 11.8)。研究对象出生时血红蛋白浓度较低(14.01±3.8 vs. 16.39±2.8 g/dL)且在整个住院期间均较低,脐血总胆红素浓度较高(4.26±1.8 vs. 2.39±1.4 mg/dL),最高胆红素浓度较高(15.27±5.8 vs. 10.24±3.4 mg/dL),肝脏超声异常更为频繁(19.9% vs. 6.3%)。由于产后输血率较高(33% vs. 3.8%)、换血需求更频繁(8.8% vs. 2.2%)、光疗时间更长且风险更高(94.3% vs. 59.1%)以及免疫球蛋白(55.7% vs. 8.1%)、肠外营养(45.5% vs. 12.9%)和抗生素(14.8% vs. 4.8%)的使用量更高,他们还需要更长时间的住院治疗。HDFN儿童胆汁淤积症的危险因素包括分娩时孕周较小、HDFN的Rh和基德血清学类型以及宫内输血需求。